Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMajor changes: add government funding/status notice and version v3.2.0; remove a specific resource and older version v3.1.0.SummaryDifference0.9%
- Check22 days agoChange DetectedTerminology refined from “Head and neck squamous cell carcinoma” to “Squamous cell carcinoma of the head and neck” and version updated from v3.0.2 to v3.1.0.SummaryDifference0.1%
- Check37 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; 'Back to Top' removed.SummaryDifference0.0%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.0%
- Check51 days agoChange DetectedThe web page has been updated to include new resources related to head and neck cancer, along with the addition of a facility name and location details, while several previous terms and categories related to antineoplastic agents and immune mechanisms have been removed.SummaryDifference1%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.